Netherlands vs Romania: Access to anti-retroviral drugs, male
Netherlands
89.0%
in 2023
Romania
89.0%
in 2024
Netherlands rank
17th
Romania rank
17th
Access to anti-retroviral drugs, male over time
- Netherlands
- Romania
How they compare
Netherlands currently reports 89.0% against 89.0% in Romania, a difference of 0.0%.
Across all 24 years both countries report, Netherlands has been ahead every year.
Netherlands ranks 17th and Romania ranks 17th of 141 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.8% | 39.9% | 10.9% | Netherlands |
| 2010s | 76.8% | 59.8% | 17.0% | Netherlands |
| 2020s | 88.2% | 76.8% | 11.5% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Netherlands or Romania?
- Netherlands, at 89.0% against 89.0% in Romania as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Netherlands and Romania?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Romania?
- 24 years are reported by both, from 2000 to 2023.
- How do Netherlands and Romania rank globally for access to anti-retroviral drugs, male?
- Netherlands ranks 17th and Romania ranks 17th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.